• Explore /
  • Poster
  • / The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide.

The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castrate-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide.

Abstract Poster

Authors

null

Siyuan S Guo

Duke University, Durham, NC

Siyuan S Guo , Susan Halabi , David M. Nanus , Daniel J. George , Emmanuel S. Antonarakis , Daniel Costin Danila , Russell Zelig Szmulewitz , Donald P. McDonnell , John D. Norris , Changxue Lu , Jun Luo , Andrew J. Armstrong

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

NCT02269982

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5060)

DOI

10.1200/JCO.2023.41.16_suppl.5060

Abstract #

5060

Poster Bd #

154

Abstract Disclosures

Similar Posters

First Author: Giulio Francolini

First Author: Karthik Giridhar

First Author: Maral DerSarkissian

First Author: Xiaolei Shi